From: The changes of immunoglobulin G N-glycosylation in blood lipids and dyslipidaemia
IgG glycans | Prin. 3 | Prin. 4 | ||
---|---|---|---|---|
β (95% CI)a | P | β (95% CI)b | P | |
Initial measurements | ||||
 GP2 | 0.046 (0.006 to 0.087) | 0.023* | − 0.012 (− 0.055 to 0.032) | 0.596 |
 GP4 | 0.035 (0.014 to 0.056) | 0.001* | − 0.015 (− 0.039 to 0.010) | 0.237 |
 GP5 | 0.035 (0.014 to 0.055) | 0.001* | 0.019 (− 0.006 to 0.044) | 0.130 |
 GP6 | 0.036 (0.015 to 0.057) | < 0.001** | − 0.010 (− 0.034 to 0.014) | 0.395 |
 GP11 | 0.020 (0.004 to 0.036) | 0.013* | 0.017 (− 0.001 to 0.035) | 0.066 |
 GP14 | − 0.022 (− 0.037 to 0.006) | 0.006* | 0.004 (− 0.014 to 0.022) | 0.642 |
 GP18 | − 0.033 (− 0.051 to 0.015) | < 0.001** | 0.006 (− 0.015 to 0.026) | 0.604 |
 GP20 | 0.014 (− 0.015 to 0.042) | 0.336 | 0.051 (0.018 to 0.084) | 0.003* |
 GP21 | 0.024 (0.004 to 0.045) | 0.020* | 0.025 (0.001 to 0.049) | 0.041* |
Sialylation | ||||
 FGS/(FG + FGS) | − 0.014 (− 0.025 to 0.003) | 0.013* | 0.001 (− 0.011 to 0.014) | 0.840 |
 FGS/(F + FG + FGS) | − 0.023 (− 0.037 to 0.008) | 0.003* | 0.006 (− 0.012 to 0.023) | 0.527 |
Bisecting GlcNAc | ||||
 FBStotal/FStotal | 0.021 (0.002 to 0.041) | 0.032* | − 0.008 (− 0.030 to 0.014) | 0.498 |
 FBS2/FS2 | 0.020 (0.001 to 0.038) | 0.039* | 0.005 (− 0.016 to 0.023) | 0.660 |
 FBS2/(FS2 + FBS2) | 0.011 (0.001 to 0.020) | 0.034* | 0.002 (− 0.009 to 0.013) | 0.740 |
Galactosylation | ||||
 G0n | 0.029 (0.012 to 0.046) | 0.001* | –0.013 (− 0.033 to 0.007) | 0.212 |
 G2n | − 0.026 (− 0.043 to 0.009) | 0.003* | 0.008 (− 0.013 to 0.027) | 0.476 |